Legence Corp. (LGN) Operating Margin
- Operating margin · 12 months: Value 0.79%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 0.79% | Operating income / revenue. Period ending 2026-06-30. $29.45M ÷ $3.75B × 100 ≈ 0.79% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 29.45M USD | Operating Income (Loss) |
| Revenue | 3.75B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 3.04B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 464.39M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29.45M | $3.75B | $3.04B | (m) | $464.39M | 0.79% |
| 2026-03-31 | $67.39M | $3.08B | $2.47B | (m) | $389.26M | 2.19% |
| 2025-12-31 | $61.58M | $2.55B | $2.01B | (m) | $342.63M | 2.41% |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $70.35M | $2.10B | $1.67B | (m) | $242.89M | 3.35% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $10.26M | $1.62B | $1.30B | (m) | $186.06M | 0.64% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.